Balance Sheet Data

AIM ImmunoTech Inc. (AIM)

$0.43

+0.00 (+1.15%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 2.111.838.783948.2714.5211.679.377.536.05
Total Cash (%)
Account Receivables 0.021.090.821.121.640.610.490.390.310.25
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 0.740.680.470.380.200.230.190.150.120.10
Accounts Payable (%)
Capital Expenditure -0.07-0.13-0.37-0.59-0.63-0.25-0.20-0.16-0.13-0.10
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.